Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Clinical trial NCT02201043 · COMPLETED
Trial details
- NCT number
- NCT02201043
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2015-02-01
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.